CHBP and caspase-3 siRNAs for renoprotection against ischemia reperfusion and CsA nephrotoxicity Aug. 4, 2014
Nymox reports efficacy findings from repeat injection phase III study of NX-1207 for BPH July 25, 2014
Pivotal study of PRT-201 for hemodialysis vascular access in patients with chronic kidney disease July 22, 2014
Regulus Therapeutics' anti-miR-21 oligonucleotide awarded FDA orphan drug status for Alport syndrome July 22, 2014
RSS